KemPharm, Inc. (ZVRA) Earnings
|
Expand Research on ZVRA
| Next EPS Date | 8/18/26 | EPS Growth Rate | +283.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +250.3% | Revenue Growth Rate | +67.6% |
| Average % Move 1-Wk after EPS | -5.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/26  |
Q126 | N/A | $0.11 | N/A | N/A | $34.2M | N/A | N/A | N/A | ||
| 5/6/26 | Q425 | $0.60 | $0.07 | +$0.53 | $36.2M | $31.96M | N/A |  | | Details | |
| 3/9/26 | Q325 | $0.19 | $0.05 | +$0.14 | $34.1M | $28.05M | N/A | | | Details | |
| 11/5/25 | Q225 | -$0.01 | -$0.03 | +$0.02 | $26.1M | $26.64M | N/A | | | Details | |
| 8/12/25 | Q125 | -$0.06 | $2.19 | -$2.25 | $25.9M | $22.49M | N/A | | | Details | |
| 5/13/25 |
Q125 | N/A | -$0.24 | N/A | $20.4M | $16.02M | N/A | N/A | N/A | ||
| 3/11/25 | Q424 | -$0.67 | -$0.40 | -$0.27 | $12M | $8.52M | N/A | | | Details | |
| 2/28/25 |
Q424 | N/A | -$0.40 | N/A | N/A | $8.52M | N/A | N/A | N/A |
